Functional Ingredients

Azantis and Aker BioMarine on krill futures

RSS

 

Todd Norton, VP of business development at Aker BioMarine, and Mickey Schuett, then director of sales at Azantis, talk with Functional Ingredients Editor-in-Chief Todd Runestad about krill's position in the market. 

Different than omega-3s from algal sources or fish oil, krill is a phospholipid rather than a triglyceride. Emerging science suggests that the omega-3s bound to phospholipids have better bioefficiency and are utilized better by the body than those bound to triglycerides. This as well as krill's ability to deliver more DHA and EPA in a smaller capsule positions it well to compete in the crowded omega-3 space. Schuett says he believes there is room for krill as well as fish oil and algal-sourced omega-3s in the industry.

What differentiates these two krill suppliers and what opportunities do they see in the market? Watch the interview to learn more.

Please or Register to post comments.

New in Supply
Oct 24, 2014
Video
Functional Ingredients

FI How-To: What's the next big thing under the deep blue sea?

Krill totally disrupted the omega-3 fish oil industry. What other marine biomass might be ripe for the healthy consumption?...More
Webinar

newhope360 webinar: The Future of non-GMO

Connect with Engredea

Sponsored Introduction Continue on to (or wait seconds) ×